Page last updated: 2024-10-21

1-(3-chlorophenyl)piperazine and Asperger Syndrome

1-(3-chlorophenyl)piperazine has been researched along with Asperger Syndrome in 1 studies

1-(3-chlorophenyl)piperazine: supposed metabolite of TRAZODONE; RN given refers to parent cpd; structure
1-(3-chlorophenyl)piperazine : A N-arylpiperazine that is piperazine carrying a 3-chlorophenyl substituent at position 1. It is a metabolite of the antidepressant drug trazodone.

Asperger Syndrome: A disorder beginning in childhood whose essential features are persistent impairment in reciprocal social communication and social interaction, and restricted, repetitive patterns of behavior, interests, or activities. These symptoms may limit or impair everyday functioning. (From DSM-5)

Research Excerpts

ExcerptRelevanceReference
"Patients with autism spectrum disorders showed a significant increase in repetitive behaviours at end-point following oral m-CPP in comparison to placebo."2.71Increased repetitive behaviours and prolactin responsivity to oral m-chlorophenylpiperazine in adults with autism spectrum disorders. ( Allen, A; Hollander, E; Iyengar, R; Novotny, S; Phillips, A; Wasserman, S, 2004)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Novotny, S1
Hollander, E1
Phillips, A1
Allen, A1
Wasserman, S1
Iyengar, R1

Trials

1 trial available for 1-(3-chlorophenyl)piperazine and Asperger Syndrome

ArticleYear
Increased repetitive behaviours and prolactin responsivity to oral m-chlorophenylpiperazine in adults with autism spectrum disorders.
    The international journal of neuropsychopharmacology, 2004, Volume: 7, Issue:3

    Topics: Adolescent; Adult; Asperger Syndrome; Autistic Disorder; Behavior; Double-Blind Method; Female; Huma

2004